Executive Summary: Key Legal and Evidentiary Issues

• The Court of Appeal addressed wrongful appropriation of professional fees by a non-pharmacist partner in violation of pharmacy ethics.

• Found that the lower court wrongly inferred accounting corrections applied in 2017 could limit damages owed for prior years without sufficient evidentiary basis.

• Determined the trial judge improperly placed the burden of proving the precise quantum of diverted funds on the wrong party.

• Confirmed that amounts tied to pharmaceutical activities cannot be retained by non-pharmacists under Article 49 of the Code of Ethics of Pharmacists.

• Held that professional income diverted contrary to law must be fully restituted when no justified offsets are proven.

• Reversed the lower court ruling and ordered the defendants to reimburse the full $1.24 million in diverted allocations.

The dispute over diverted professional pharmacy revenues

The case arose from a dispute between two business entities involved in the joint operation of a pharmacy in Granby, Québec. The appellant, Pharmacie Jean-Philippe Robert, Pharmacien inc., was owned by pharmacist Jean-Philippe Robert and was responsible for the professional (dispensary) side of the pharmacy. The respondent, Martin Pinel inc., controlled by Guy Pinel, managed the commercial side of the business. Their working relationship was formalized through a series of agreements signed in 2008, including a management agreement and terms for cost and revenue sharing.

Between 2009 and 2016, Martin Pinel inc. and Guy Pinel engaged in accounting practices that diverted over $1.2 million in professional allocations—specifically, revenues from the sale of generic medications—which by law and ethics belonged exclusively to the pharmacist or a licensed pharmacist corporation. These acts constituted serious and intentional misconduct. The amounts in question fell under Article 49 of the Code of Ethics of Pharmacists, a rule of public order that strictly prohibits sharing profits from medication sales with non-pharmacists, unless within a licensed pharmacist partnership or corporation.

Lower court’s findings and reasoning

The Québec Superior Court acknowledged that the respondents had committed serious faults and caused harm to the appellant. However, it declined to award the full amount of the diverted funds. The judge relied on financial corrections jointly made by the parties for the year 2017, where only a portion of the reallocated funds actually increased the appellant's pre-tax profits. From this, the judge inferred that similar adjustments would have applied to earlier years, meaning the full amount of the diverted funds might not have directly benefited the appellant even if properly allocated. Additionally, the judge found the appellant failed to sufficiently prove what portion of the diverted funds it was rightfully owed and thus rejected its claim for the 2009–2016 period.

The appeal and reversal by the Québec Court of Appeal

The Court of Appeal overturned the lower court’s decision. It held that the inferences drawn by the trial judge lacked sufficient evidentiary support, particularly given the absence of expert accounting testimony or detailed explanations for the 2017 financial corrections. It was deemed speculative to assume that similar adjustments would apply across earlier years.

The appellate judges also found that the burden of proof regarding the need for any offsetting corrections rested with the defendants, not the appellant. Since the misappropriated funds were governed by a rule of public order, the pharmacist corporation had a clear right to full recovery unless the respondents could prove valid contractual grounds or accounting justifications for retaining any portion. No such proof was provided.

Final decision and impact

The Court of Appeal allowed the appeal, set aside the trial court’s partial denial, and ordered the full recovery of the $1,243,023.83 in diverted allocations, plus interest and additional indemnity. This ruling reinforces the strict enforcement of ethical boundaries in professional fields like pharmacy and clarifies the evidentiary expectations when disputing claims involving public order rules.